Covering: This market study segments the global cell counting market by application (mass spectrometry, cell imaging, flow cytometry, and hemato analyzer), by product (equipment and reagents), and by geography (APAC, Americas, and EMEA). Leading vendors in this market are BD, Bio-Rad, EMD Millipore, and Thermo Fisher Scientific.Market outlook of the global cell counting market
Cell counters are devices that aid in determining live or dead cells concentration and help to count the blood cells in biological samples. This market is estimated to grow at a steady rate during the forecast period and is positively influenced by factors like the growing establishment of diagnostic centers in rural areas. Additionally, the ability of these devices to provide rapid test results is a significant factor that results in its steady CAGR of more than 7% by 2019.
Technavio’s market research analyst has estimated the Americas to account for more than 41% of the total market share by 2019. The increasing adoption of automated analyzers by laboratories in the North American region is a critical factor that drives market growth in the Americas during the forecast period.
Application-based segmentation of the cell counting market
Mass spectrometry is used to understand the molecular mass and structural information of cells. This segment currently dominates the global market for cell counting devices and factors like increased speed, higher accuracy, and high portability of these devices are expected to foster market growth during the next four years.
Product-based segmentation of the cell counting market
Technavio market research analysts estimate the reagents segment to account for 80% of the total sales by 2019. Since most diagnostic centers rent equipment and purchase reagents, the sale of reagents is expected to increase steadily during the next four years. The usability of these reagents across a variety of tests is a key factor that drives sales during the forecast period.
Competitive landscape and key vendors
This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers that provide infectious disease diagnostic products. These vendors maintain their hold on the market by providing premium priced products to laboratories and also by forming partnerships with SMEs that enter the market due to its low entry barrier.
Key vendors in this market are -
Thermo Fisher Scientific
Other prominent vendors in this market are AccuBioTech, Agappe Diagnostics, Analyticon, Beckman Coulter, ChemoMetec, EKF Diagnostic, ERBA Mannheim, HomeCue, Horiba Scientific, Human Diagnostics, Logos Biosystem, Mindray, Melet Schloesing Laboratories, Nihon Kohden, Olympus LifeScience Solution, Rayto, SFRI, and Sysmex Corporation.
Key questions answered in the report include
What will the market size and the growth rate be in 2019?
What are the key factors driving the global cell counting market?
What are the key market trends impacting the growth of the global cell counting market?
What are the challenges to market growth?
Who are the key vendors in the global cell counting market?
What are the market opportunities and threats faced by the vendors in the global cell counting market?
Trending factors influencing the market shares of the EMEA, Americas, and APAC?
What are the key outcomes of the five forces analysis of the global cell counting market?
Technavio also offers customization on reports based on specific client requirement.
Global Cell-based Assay Market 2015-2019
Stem Cell Banking Market in India 2015-2019
Technavio Announces the Publication of its Research Report – Global Cell Counting Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Cell Counting Market: BD, Bio-Rad, EMD Millipore and Thermo Fisher Scientific
Other Prominent Vendors in the market are: AccuBioTech, Agappe Diagnostics, Analyticon, Beckman Coulter, ChemoMetec, EKF Diagnostic, ERBA Mannheim, HomeCue, Horiba Scientific, Human Diagnostics, Logos Biosystem, Mindray, Melet Schloesing Laboratories, Nihon Kohden, Olympus LifeScience Solution, Rayto, SFRI, and Sysmex Corporation.
Commenting on the report, an analyst from Technavio’s team said: “There are several low-cost and portable cell monitoring devices in the pipeline. Currently there are some portable automated CD4+ T-cell counters in the market such as PointCare NOW (Paratec, Pima Test (Alere), Daktari CD4+ (Daktari). These devices use 25 microliters of blood and provide the results on the same day. The PointCare NOW and CyFlow mini POC measures the absolute CD4+ T-cell count.”
According to the report, development of highly sensitive POCT and automation of cell counting equipment will drive the growth of the global cell monitoring market. The POC diagnostic tests are mostly favored by hospitals and clinics and are affordable for the patients. The manufacturers are developing portable POC equipment for cell counting.
Further, the report states that the cell counting equipment is highly technical, containing a complex system made of many parts such as electrodes, highly senstive sensors, and a monitor. A high degree of technical expertise is required to effectively use this equipment to record data and diagnose the diseases. There is a risk of false recordings due to artifacts arising from other sites.